NCT03283176View on ClinicalTrials.gov

Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without Ribavirin

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 1, 2018

Primary Completion Date

March 1, 2019

Study Completion Date

January 14, 2020

Conditions
Liver CirrhosesChronic Hepatitis cDirectly Acting Antivirals
Interventions
DIAGNOSTIC_TEST

Vitamin B12 and Folic Acid

Vitamin B12 and Folic Acid measurement by ELISA technique

Trial Locations (1)

71111

Mohamed Shaban Redwan Helal, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03283176 - Hematologic Profile, Vit. B12 and Folic Acid in Cirrhotics Received Sofosbuvir and Daclatasvir With or Without Ribavirin | Biotech Hunter | Biotech Hunter